Skip to content
10-Q

Quarterly Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-18-000105

← back to feed
Filed
Feb 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Feb 14, 2018 29.79M sh
Stockholders Equity Q3 2017 · Dec 31, 2017 $98.67M
Stockholders Equity Q3 2017 · Mar 31, 2017 $84.88M
Current Liabilities Q3 2017 · Dec 31, 2017 $1.36M
Current Liabilities Q3 2017 · Mar 31, 2017 $2.99M
Current Assets Q3 2017 · Dec 31, 2017 $24.69M
Current Assets Q3 2017 · Mar 31, 2017 $18.48M
Total Assets Q3 2017 · Dec 31, 2017 $102.88M
Total Assets Q3 2017 · Mar 31, 2017 $90.29M
Capex Q3 2017 · Dec 31, 2016 $1.37M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $9.78M
Cash And Equivalents Q3 2017 · Mar 31, 2016 $7.64M
Sga Expense Q3 2017 · Dec 31, 2016 $1.14M
Sga Expense Q3 2017 · Dec 31, 2016 $2.72M
Rd Expense Q3 2017 · Dec 31, 2016 $279.59K
Rd Expense Q3 2017 · Dec 31, 2016 $754.49K
Net Income Q3 2017 · Dec 31, 2016 $2.59M
Net Income Q3 2017 · Dec 31, 2016 $6.16M
Operating Income Q3 2017 · Dec 31, 2016 $3.43M
Operating Income Q3 2017 · Dec 31, 2016 $8.19M
Gross Profit Q3 2017 · Dec 31, 2016 $5.81M
Gross Profit Q3 2017 · Dec 31, 2016 $14.2M
Revenue Q3 2017 · Dec 31, 2016 $14.17M
Revenue Q3 2017 · Dec 31, 2016 $35.48M